PILICHOU, KALLIOPI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.052
AS - Asia 7.539
EU - Europa 5.328
SA - Sud America 1.343
AF - Africa 1.158
Continente sconosciuto - Info sul continente non disponibili 315
OC - Oceania 113
Totale 28.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.107
IT - Italia 2.374
SG - Singapore 2.213
CN - Cina 1.224
VN - Vietnam 1.083
BR - Brasile 850
HK - Hong Kong 799
BD - Bangladesh 496
SE - Svezia 372
DE - Germania 316
CA - Canada 278
IN - India 255
FR - Francia 246
FI - Finlandia 242
NL - Olanda 218
GB - Regno Unito 217
PL - Polonia 141
RU - Federazione Russa 126
AR - Argentina 108
JP - Giappone 107
IQ - Iraq 104
TR - Turchia 96
MX - Messico 94
PH - Filippine 89
ZA - Sudafrica 81
ID - Indonesia 80
BJ - Benin 79
SA - Arabia Saudita 77
GR - Grecia 75
PK - Pakistan 75
UA - Ucraina 75
ES - Italia 73
EC - Ecuador 70
JM - Giamaica 70
AT - Austria 67
CR - Costa Rica 63
UZ - Uzbekistan 48
EG - Egitto 47
KR - Corea 47
VE - Venezuela 47
CO - Colombia 46
NI - Nicaragua 46
MA - Marocco 45
PE - Perù 45
CI - Costa d'Avorio 44
AE - Emirati Arabi Uniti 43
CL - Cile 43
HN - Honduras 43
IE - Irlanda 43
MY - Malesia 43
CH - Svizzera 42
PY - Paraguay 41
IL - Israele 40
BE - Belgio 39
DZ - Algeria 39
RS - Serbia 39
AZ - Azerbaigian 38
LV - Lettonia 38
NP - Nepal 38
AL - Albania 37
PS - Palestinian Territory 37
TH - Thailandia 37
UY - Uruguay 37
DK - Danimarca 36
JO - Giordania 35
MK - Macedonia 35
PA - Panama 35
RO - Romania 35
LB - Libano 34
NO - Norvegia 34
YE - Yemen 34
AU - Australia 33
HR - Croazia 33
KZ - Kazakistan 33
SI - Slovenia 33
YT - Mayotte 33
DO - Repubblica Dominicana 32
EE - Estonia 32
GT - Guatemala 32
IR - Iran 32
LU - Lussemburgo 32
TT - Trinidad e Tobago 32
TN - Tunisia 31
AO - Angola 30
CV - Capo Verde 30
GF - Guiana Francese 30
KE - Kenya 30
KG - Kirghizistan 30
LA - Repubblica Popolare Democratica del Laos 30
BY - Bielorussia 29
MG - Madagascar 29
AD - Andorra 28
BA - Bosnia-Erzegovina 28
ET - Etiopia 28
MN - Mongolia 28
MU - Mauritius 28
SO - Somalia 28
BB - Barbados 27
CY - Cipro 27
MD - Moldavia 27
Totale 27.325
Salva come PNG Salva come JPEG
Città #
Ashburn 1.600
San Jose 1.428
Singapore 1.346
Fairfield 956
Hong Kong 724
Houston 468
Chandler 467
Woodbridge 467
Ann Arbor 432
Los Angeles 363
Seattle 363
Cambridge 338
Ho Chi Minh City 327
Wilmington 320
Santa Clara 300
Council Bluffs 295
Hanoi 260
Beijing 248
Milan 247
Rome 185
New York 165
Padova 154
Boardman 150
Chicago 129
San Diego 128
Helsinki 127
Jacksonville 126
Lauterbourg 112
Munich 107
Princeton 104
Salt Lake City 97
Buffalo 80
Orem 78
São Paulo 78
Cotonou 76
Bytom 73
Medford 72
Da Nang 70
Dallas 66
Phoenix 62
Roxbury 60
Tokyo 59
Naples 58
Padua 58
Turin 56
Denver 53
San José 53
Bologna 52
Des Moines 52
Montreal 50
Hefei 49
Baghdad 47
Warsaw 47
Haiphong 46
Turku 46
Managua 44
Abidjan 43
Brooklyn 42
Guangzhou 42
Johannesburg 42
London 41
Tashkent 41
Nanjing 37
Vienna 36
Amsterdam 35
Chennai 35
Frankfurt am Main 35
Kingston 35
Panama City 35
Riga 35
Toronto 35
Atlanta 34
Bari 34
Verona 34
Amman 33
Baku 33
Stockholm 33
Villafranca Padovana 33
Istanbul 32
Dublin 31
Montevideo 31
Nuremberg 31
Brasília 29
Lahore 29
Praia 28
Bridgetown 27
Riyadh 27
The Dalles 27
Andorra la Vella 26
Antananarivo 26
Bishkek 26
Florence 26
Libreville 25
Noumea 25
Ulan Bator 25
Boston 24
Dakar 24
Dar es Salaam 24
Rio de Janeiro 24
Vientiane 24
Totale 15.412
Salva come PNG Salva come JPEG
Nome #
'Hot phase' clinical presentation in arrhythmogenic cardiomyopathy 615
The 2020 “Padua Criteria” for Diagnosis and Phenotype Characterization of Arrhythmogenic Cardiomyopathy in Clinical Practice 577
Loss of cardiac Wnt/β-catenin signalling in Desmoplakin-deficient AC8 zebrafish models is rescuable by genetic and pharmacological intervention 395
Large Genomic Rearrangements of Desmosomal Genes in Italian Arrhythmogenic Cardiomyopathy Patients 378
Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse 374
Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy 373
Arrhythmogenic cardiomyopathy 350
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report 346
A microRNA expression profile as non-invasive biomarker in a large arrhythmogenic cardiomyopathy cohort 327
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy 325
Hyperactivation of Wnt/β-catenin and Jak/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue 324
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy 321
Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. 310
Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy 305
Zebrafish models for Arrhythmogenic Cardiomyopathy Type 8: a starting platform for exercise stress test and drug treatment 302
Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance 300
Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death 297
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria 293
Homozygous desmocollin-2 mutations and arrhythmogenic cardiomyopathy 292
Desmoplakin knock-downs in zebrafish recapitulate arrhythmogenic cardiomiopathy type 8 and involve Wnt/beta-catenin signaling in AC8 pathogenesis 289
Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. 289
Arrhythmogenic Cardiomyopathy 285
Contemporary diagnostic approach to arrhythmogenic cardiomyopathy: The three-step work-up 282
PHENOTYPIC EXPRESSION IS A PREREQUISITE FOR MALIGNANT ARRHYTHMIC EVENTS AND SUDDEN CARDIAC DEATH IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 278
The ARVD/C genetic variants database: 2014 update. 268
A Comprehensive Analysis of Non-Desmosomal Rare Genetic Variants in Arrhythmogenic Cardiomyopathy: Integrating in Padua Cohort Literature-Derived Data 266
Diagnosis of arrhythmogenic cardiomyopathy: 20 years of progress and innovation 263
Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy. 262
Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis 260
Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. 255
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy 254
Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies 253
Filamin C variant-associated Cardiomyopathy: A Pooled Analysis of Individual Patient Data to Evaluate the Clinical Profile and Risk of Sudden Cardiac Death 249
Development of a novel next-generation sequencing panel for diagnosis of quantitative spermatogenic impairment 246
Natural History and Clinical Outcomes of Patients With DSG2/DSC2 Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy 246
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models 245
Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes 243
Papillary Muscles Abnormalities in Athletes With Otherwise Unexplained T-Wave Inversion in the ECG Lateral Leads 242
Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia 240
The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes 239
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic 234
The Role of MicroRNAs in Arrhythmogenic Cardiomyopathy: Biomarkers or Innocent Bystanders of Disease Progression? 234
The "Padua classification" of cardiomyopathies: Combining pathobiological basis and morpho-functional remodeling 232
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 231
Scarring/arrhythmogenic cardiomyopathy 230
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy 228
Update on cardiomyopathies and sudden cardiac death 225
Neuropeptide Y promotes adipogenesis of human cardiac mesenchymal stromal cells in arrhythmogenic cardiomyopathy 225
Management of arrhythmogenic right ventricular cardiomyopathy 221
Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities. 220
Zebrafish models for ARVC8 analysis and drug discovery 219
Genetic Background and Clinical Features in Arrhythmogenic Left Ventricular Cardiomyopathy: A Systematic Review 218
Identification of Rare LRP5 Variants in a Cohort of Males with Impaired Bone Mass 216
Zebrafish models for ARVC8 analysis and drug discovery 216
Peripheral nerve involvement in wild-type transthyretin amyloidosis 214
A novel DSP zebrafish model reveals training- and drug-induced modulation of arrhythmogenic cardiomyopathy phenotypes 212
Pregnancy in Women with Arrhythmogenic Left Ventricular Cardiomyopathy 210
Response to letters regarding article, "arrhythmic mitral valve prolapse and sudden cardiac death" 210
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 206
Assessing the significance of pathogenic mutations and autopsy findings in the light of 2010 arrhythmogenic right ventricular cardiomyopathy diagnostic criteria: a clinical challenge. 206
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria 205
Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease 201
Pathobiology of arrhythmogenic cardiomyopathy 201
An International Evidence Based Reappraisal of Genes Associated with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) using the ClinGen Framework 201
Response to Letters Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death" 196
Myocardial Tissue Characterization in Arrhythmogenic Cardiomyopathy: Comparison Between Endomyocardial Biopsy and Cardiac Magnetic Resonance 196
Autonomic dysfunction as first presentation of Glu54Gln transthyretin amyloidosis 194
Arrhythmogenic Right Ventricular Cardiomyopathy 194
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (vol 55, pg 587, 2010) 193
TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse 193
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy 191
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 188
Arrhythmogenic cardiomyopathy: Pathology, genetics, and concepts in pathogenesis 188
Molecular genetic testing in athletes: Why and when a position statement from the Italian society of sports cardiology 188
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance 187
The genetic architecture of Plakophilin 2 cardiomyopathy 187
Incidental cardiac uptake of 99mTc-diphosphonates is predictive of poor outcome: data from 9616 bone scintigraphies 185
Wnt/ Beta-catenin signaling reduction as a therapeutically targetable mechanism in different zebrafish models for Arrhythmogenic Cardiomyopathy. 183
Pathologic substrates of sudden cardiac death during sports 182
Is Congenital Muscular Mitral-Aortic Discontinuity Another Feature of Obstructive Hypertrophic Cardiomyopathy? A Pathology Validation Study 181
New Diagnostic Approach to Arrhythmogenic Cardiomyopathy: The Padua Criteria 181
Arrhythmogene rechtsventrikuläre Kardiomyopathie: Beitrag der kardialen Magnetresonanztomographie bei der Diagnosestellung 179
Pharmacotherapy and other therapeutic modalities for managing arrhythmogenic right ventricular cardiomyopathy. 179
Genetic and immunogenetic basis of myocarditis 178
Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy 177
2025 ESC Guidelines for the management of myocarditis and pericarditis 176
Arrhythmogenic cardiomyopathy: the ongoing search for mechanism-driven therapies meets extracellular vesicles 176
Hot phase episodes in Arrhythmogenic cardiomyopathy: More than just a Desmoplakin issue? 175
Intercalated Disc Abnormalities, Reduced Na+ current density and Conduction Slowing in Desmoglein-2 Mutant Mice Prior to Cardiomyopathic Changes 174
The changing spectrum of arrhythmogenic (right ventricular) cardiomyopathy. 174
Molecular biology and the clinicalmanagement of arrhythmogenic right ventricular cardiomyopathy/dysplasia. 173
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report 171
Sudden Arrhythmic Death and the cardiomyopathies: molecular genetics and pathology. 169
A de novo ryanodine receptor 2 gene variant in a case of sudden cardiac death 169
Sudden cardiac death with normal heart Molecular autopsy. 168
Nonischemic Left Ventricular Scar: Sporadic or Familial? Screen the Genes, Scan the Mutation Carriers 167
The complex molecular genetics of arrhythmogenic cardiomyopathy 167
Genetics of Cardiomyopathies: Arrhytmogenic Right ventricular Cardiomyopathy 166
REPRODUCIBILITY OF VENTRICULAR ARRHYTHMIAS AT EXERCISE TESTING FOR PREDICTION OF NON-ISCHEMIC LEFT VENTRICULAR SCAR IN ATHLETES 164
Cardiac arrest at rest and during sport activity: causes and prevention 162
Totale 23.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.381
article - articoli 71.866
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.997
Totale 156.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.129 0 0 0 122 88 133 74 222 90 45 87 268
2022/20231.083 167 105 42 121 165 119 17 114 134 20 56 23
2023/2024909 30 111 88 92 56 101 78 32 60 47 120 94
2024/20253.632 34 223 165 142 337 166 291 343 308 234 545 844
2025/202615.082 816 957 1.779 2.262 1.334 686 2.075 1.287 1.548 845 807 686
2026/20272.766 848 736 795 387 0 0 0 0 0 0 0 0
Totale 28.848